Skip to Main Content

2,807

Views

3

CrossRef citations to date

0

Altmetric

Review

Budget impact analysis of introducing a non-reconstituted, hexavalent vaccine for pediatric immunization in the United Kingdom

D. A. R. Mathijssena Pharmerit - an OPEN health company, Rotterdam, The NetherlandsCorrespondence[email protected]
View further author information

,

M. Heisena Pharmerit - an OPEN health company, Rotterdam, The Netherlands

https://orcid.org/0000-0002-5339-6606 View further author information

,

J. F. Clark-Wrightb Sanofi Pasteur UK & Ireland, Reading, United KingdomView further author information

,

L. J. Wolfsonc Merck & Co., Inc., Kenilworth, NJ, USA

https://orcid.org/0000-0002-6454-3368 View further author information

,

X. Luc Merck & Co., Inc., Kenilworth, NJ, USAView further author information

,

S. Carrolb Sanofi Pasteur UK & Ireland, Reading, United KingdomView further author information

,

B.C.P. van Dijka Pharmerit - an OPEN health company, Rotterdam, The NetherlandsView further author information

,

S. L. Klijna Pharmerit - an OPEN health company, Rotterdam, The NetherlandsView further author information

&

B. Alemayehuc Merck & Co., Inc., Kenilworth, NJ, USAView further author information